Perspectives

The importance of diversifying the ADNI population

Plans to reduce sampling bias in the ADNI project

Solutions to increase enrolment of under-represented minorities in the ADNI

Highlights from the AD/PD 2022 conference

Antibody-based therapy in Alzheimer’s disease: future outlook

Considering vascular pathologies when interpreting Alzheimer’s disease trial results

Promoting dementia research in the Middle East

Strengthening diversity in dementia biomarkers research

Greatest needs in dementia research: early diagnosis

Reframing the way we think about Alzheimer’s disease

Activation of the innate immune system in Alzheimer’s Disease

The potential of vaccination for neurodegenerative disease

What’s the future of Alzheimer’s disease therapeutics?

Discussing the future of aducanumab in dementia care at AAN 2022

Highlights from ARUK 2022

Future perspectives in Alzheimer’s research